Longitudinal evaluation of visual P300 amplitude in clinical high-risk subjects: An event-related potential study.
Naoya OribeYoji HiranoElisabetta Del ReRaquelle I Mesholam-GatelyKristen A WoodberryTakefumi UenoShigenobu KanbaToshiaki OnitsukaMartha E ShentonKevin M SpencerMargaret A NiznikiewiczPublished in: Psychiatry and clinical neurosciences (2020)
Visual P300 amplitude was found to be reduced in CHR individuals compared with HC. We note that this finding is in subjects who did not convert to psychosis at 1-year follow-up. The association between visual P300 amplitude and symptoms suggests that for CHR who often experience clinical symptoms and seek medical care, visual P300 may be an important index that reflects the pathophysiological impairment underlying such clinical states.